10-QPeriod: Q1 FY2011

AGILENT TECHNOLOGIES, INC. Quarterly Report for Q1 Ended Jan 31, 2011

Filed March 9, 2011For Securities:A

Summary

Agilent Technologies, Inc. reported strong financial performance for the quarter ended January 31, 2011, with net revenue increasing by 25% year-over-year to $1.519 billion. This growth was driven by a significant increase in orders across all business segments, particularly in Life Sciences and Chemical Analysis, partly due to the integration of the Varian, Inc. acquisition. Net income also saw a substantial rise, reaching $193 million compared to $79 million in the prior year's comparable period, indicating improved profitability and effective cost management. The company's operational efficiency improved, with operating margins increasing to 13.9% from 7.8% year-over-year. Cash flow from operations was robust at $120 million, demonstrating the company's ability to generate cash from its core business. Agilent continues to focus on integrating the Varian acquisition, expecting to achieve significant cost savings and revenue synergies. The company also highlighted its ongoing commitment to research and development, aiming to maintain approximately 10% of revenues, and its strategic manufacturing capacity expansion for its electronic measurement business.

Financial Statements
Beta

Key Highlights

  • 1Net revenue grew 25% year-over-year to $1.519 billion, driven by strong order growth across all segments.
  • 2Net income significantly increased to $193 million from $79 million in the prior year's quarter.
  • 3Operating margin improved to 13.9% from 7.8% year-over-year, reflecting increased volume and cost efficiencies.
  • 4Cash flow from operating activities was $120 million, a substantial improvement from $30 million in the prior year.
  • 5The Varian, Inc. acquisition integration is progressing, with expectations of significant cost savings and revenue synergies.
  • 6The company is strategically increasing manufacturing capacity for its electronic measurement business due to current demand.
  • 7Research and Development spending remains a focus, targeted at approximately 10% of revenue.

Frequently Asked Questions

The acquisition of Varian, Inc., completed in May 2010, significantly contributed to Agilent's revenue growth, accounting for approximately 6 percentage points of the total 25% revenue increase. While the integration process involved some initial shipment and invoicing delays, the company expects to realize substantial cost savings and revenue synergies from the combined entity.

Agilent anticipates continued growth driven by strong demand in its Life Sciences and Chemical Analysis segments, supported by the integration of Varian's product portfolio. The Electronic Measurement segment is also showing robust performance, particularly in digital applications and communications test. The company remains focused on driving synergies and cost efficiencies, which are expected to support profitability.

Agilent maintained a strong liquidity position with $2.638 billion in cash and cash equivalents as of January 31, 2011. The company generated $120 million in cash from operations during the quarter. Agilent also has a $330 million unsecured credit facility, which it had no outstanding borrowings against as of the reporting date, indicating ample financial flexibility.

Key risks include the impact of depressed general economic conditions on customer demand, the need for continuous innovation and successful new product introductions, potential supply chain disruptions due to outsourcing, and the successful integration of the Varian acquisition. Geopolitical and currency exchange rate fluctuations also pose risks due to the company's global operations.